Xencor Inc (XNCR)
23.60
+0.42
(+1.81%)
USD |
NASDAQ |
Nov 08, 16:00
23.60
0.00 (0.00%)
After-Hours: 20:00
Xencor Revenue (TTM): 85.16M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 85.16M |
| June 30, 2024 | 133.62M |
| March 31, 2024 | 162.18M |
| December 31, 2023 | 168.34M |
| September 30, 2023 | 145.26M |
| June 30, 2023 | 113.39M |
| March 31, 2023 | 98.05M |
| December 31, 2022 | 164.58M |
| September 30, 2022 | 296.98M |
| June 30, 2022 | 289.37M |
| March 31, 2022 | 326.64M |
| December 31, 2021 | 275.11M |
| September 30, 2021 | 162.95M |
| June 30, 2021 | 178.63M |
| March 31, 2021 | 124.27M |
| December 31, 2020 | 122.69M |
| September 30, 2020 | 84.36M |
| June 30, 2020 | 70.75M |
| March 31, 2020 | 77.15M |
| December 31, 2019 | 156.70M |
| September 30, 2019 | 164.75M |
| June 30, 2019 | 172.03M |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 51.76M |
| March 31, 2017 | 105.27M |
| December 31, 2016 | 109.02M |
| September 30, 2016 | 102.83M |
| June 30, 2016 | 98.52M |
| March 31, 2016 | 33.52M |
| December 31, 2015 | 27.76M |
| September 30, 2015 | 11.67M |
| June 30, 2015 | 9.017M |
| March 31, 2015 | 8.827M |
| December 31, 2014 | 9.52M |
| September 30, 2014 | 5.60M |
| June 30, 2014 | 7.914M |
| March 31, 2014 | 11.01M |
| December 31, 2013 | 10.17M |
| September 30, 2013 | 10.85M |
| June 30, 2013 | 9.267M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
70.75M
Minimum
Jun 2020
326.64M
Maximum
Mar 2022
161.81M
Average
150.98M
Median
Revenue (TTM) Benchmarks
| Biogen Inc | 9.608B |
| Dynavax Technologies Corp | 249.70M |
| SINTX Technologies Inc | 1.438M |
| Fulcrum Therapeutics Inc | -- |
| Moderna Inc | 4.988B |